AbbVie to Test HIV Drug as a Potential Coronavirus Treatment

As the COVID-19 epidemic continues to spread worldwide, the race to find treatments and vaccines for the disease is heating up. Among those searching for solutions is AbbVie (NYSE:ABBV), which is investigating whether its HIV drug Kaletra could be a treatment for COVID-19.